+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Nasogastric Tube Market Size, Share & Industry Trends Analysis Report by Indication, Patient Type, Type, End-Use, Regional Outlook and Forecast, 2022-2028

  • PDF Icon

    Report

  • 244 Pages
  • March 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5778836
The Global Nasogastric Tube Market size is expected to reach $669.5 Million by 2028, rising at a market growth of 5.2% CAGR during the forecast period.

A nasogastric (NG) tube is used to enter the stomach through the nose, nasopharynx, and throat. It is a tube made of plastic and elastic that has bidirectional potential and is flexible. These devices can provide enteral nutrition for up to six weeks. In addition, NG tubes are routinely used to provide medication and nourishment, add contrast to a stomach for X-rays, remove air or liquids from the stomach, and protect the bowel following surgery or during bowel rest.



Appropriate dietary intake is essential for overall health, wellness, and illness prevention. Often, nasogastric (NG) tubes are used to administer enteral nourishment and medications to infants, adults, and geriatric patients who have difficulty eating and digesting food and medication. In addition, essential nutrition and calories are restricted for prematurely born and ill infants. In these circumstances, nasogastric tubes deliver important dietary components and drugs.

The NG tube is guided into the nasal cavity to enter the stomach, bypassing the nasopharynx and esophagus. It is often made of rubber or plastic and is characterized by its flexibility & bidirectional potential. In addition, it is used to remove undesired stomach contents, deplete gastric chemicals, decompress the stomach, and remove poisonous semi-solids and liquids from the stomach. The NG tube allows access to the gastrointestinal system, which assists in treating bowel reconstruction and stomach immobility.

Increasing preterm births and a growing preference for enteral feeding are the primary reasons driving the expansion of the nasogastric tube market. In addition, infants born prematurely have a limited supply of vital nutrients and calories for sustaining metabolic activity; as a result, this becomes crucial to provide them with adequate nutrition and energy. Hence, the nasogastric tubes provide sufficient nutrition to prematurely born children, increasing the demand for these tubes in the market and positively affecting the market's growth in the coming years.

COVID-19 Impact Analysis

The shift in emphasis within the medical sector towards COVID-19 treatment has reduced financing for research and development activities relating to enteral nutrition. In addition, the number of patients admitted to intensive care units (ICUs) continued to rise throughout the pandemic. During the pandemic, there was a discernible rise in the number of COVID-19 patients who required nasojejunal and nasogastric tubes. Because of this, the nasogastric tube market was able to grow significantly during the pandemic period.

Market Growth Factors

Growing occurrence of premature births

Prematurity is the biggest cause of death among children under five worldwide. WHO estimates that over 15 million babies are prematurely born each year. This is more than one in every ten children. Around one million children die annually owing to problems associated with preterm birth. Several survivors face a lifetime of handicaps, including learning disorders and vision and hearing issues. Infants may be born prematurely due to spontaneous preterm labor or a medical indication to schedule an early inducement of labor or cesarean birth. Thus, the rising occurrence of preterm birthswill contribute to the growth of the market for nasogastric tubes.

Growing life expectancy and geriatric population

Life expectancy is increasing. Most of the individuals today can expect to live well into their sixties and beyond. Every nation in the globe is observing an increase in the number and proportion of its elderly population. One in six individuals will be 60 or older by the year 2030. The percentage of the world's population aged 60 and over will rise from 1 billion in 2020 to 1.4 billion in 2050. By 2050, the global population aged 60 and over will have doubled (2.1 billion). The number of people aged 80 and older is projected to treble between 2020 and 2050, reaching 426 million by 2050. These factors are contributing to the growth of the market.

Market Restraining Factors

Certain complications associated with NG tubes

If the tube becomes clogged or fails and cannot decompress the stomach, it may increase the risk of aspiration due to the stenting effect. Long-term NG tube use can irritate the gastric lining, resulting in gastrointestinal hemorrhage. Electrolyte problems, such as hypokalemia, can arise in patients undergoing extensive NG tube irrigation. Persistent pressure on one part of the nare might result in nasal pressure ulcers or necrosis. Due to these issues of a nasogastric tube, patients, as well as healthcare providers, may not prefer inserting nasogastric tubes, which may result in hampering the market growth.

Patient Type Outlook

Based on patient type, the nasogastric tube market is segmented into adult, pediatric and geriatric. The pediatric segment covered a considerable revenue share in the nasogastric tube market in 2021. Infants who are unwell or premature may be unable to breastfeed or suck from a bottle well enough. The nasogastric tube can provide all or some of the baby's nutrition. This strategy is the most efficient and safest way to provide a nutritious diet. Oral medication can also be given through the tube.



Indication Outlook

By indication, the nasogastric tube market is categorized into stomach cancer, esophageal cancer, IBD, chronic kidney disease, dysphagia and others. The esophageal cancer segment recorded a remarkable revenue share in the nasogastric tube market in 2021. Cancer, known as esophageal cancer, affects the esophagus cells, the muscular tube that transports food and liquids from the throat to the stomach. The primary factor fueling the segment's expansion is the rising incidence of chronic esophageal inflammation that may be brought on by gastroesophageal reflux disease (GERD).

Type Outlook

On the basis of type, the nasogastric tube market is divided into small-bore feeding tubes, and large-bore feeding tubes. The large-bore feeding tubes segment garnered a significant revenue share in the nasogastric tube market in 2021. Large-bore feeding tubes may be employed for feeding or giving medication, but their principal purposes are gastric suctioning or decompression. Another purpose of a large-bore nasogastric tube is to measure stomach pH or residual volume.

End-use Outlook

Based on end-use, the nasogastric tube market is bifurcated into hospitals & nursing homes and home care. The hospital & nursing home segment registered the maximum revenue share in the nasogastric tube market in 2021. The increasing frequency of ingesting and gastrointestinal problems among an older population is the primary factor driving the hospital sector. When this occurs, supplemental nutrients must be administered via the nasogastric channel, which reduces the need for nasogastric tube feeding.

Regional Outlook

Region wise, the nasogastric tube market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region led the nasogastric tube market by generating the highest revenue share. This development is attributable to factors like the expanding number of critical care units and the ageing population in nations such as the United States, Canada, and Mexico. Furthermore, the increasing incidence of obesity & digestive problems is one of the most important reasons for the increase in demand. In addition, R&D efforts associated with NG tube products are anticipated to rise during the forecast period.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Cardinal Health, Inc., QMD, Angiplast Pvt. Ltd., Securmed Spa, Vygon SAS, Andersen Products, Inc. (Weiler Abrasives Group), Guangdong Baihe Medical Technology Co., Ltd. and Poly Medicure Ltd.

Scope of the Study

By Indication

  • Dysphagia
  • Chronic Kidney Disease
  • Inflammatory Bowel Disease (IBD)
  • Esophageal Cancer
  • Stomach Cancer
  • Others

By Patient Type

  • Adult
  • Geriatric
  • Pediatric

By Type

  • Small-bore Feeding Tubes
  • Large-bore Feeding Tubes

By End-Use

  • Hospitals & Nursing Homes
  • Home Care

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Becton, Dickinson and Company
  • Medtronic PLC
  • Cardinal Health, Inc.
  • QMD
  • Angiplast Pvt. Ltd.
  • Securmed Spa
  • Vygon SAS
  • Andersen Products, Inc. (Weiler Abrasives Group)
  • Guangdong Baihe Medical Technology Co., Ltd.
  • Poly Medicure Ltd.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Nasogastric Tube Market, by Indication
1.4.2 Global Nasogastric Tube Market, by Patient Type
1.4.3 Global Nasogastric Tube Market, by Type
1.4.4 Global Nasogastric Tube Market, by End-Use
1.4.5 Global Nasogastric Tube Market, by Geography
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Nasogastric Tube Market by Indication
3.1 Global Dysphagia Market by Region
3.2 Global Chronic Kidney Disease Market by Region
3.3 Global Inflammatory Bowel Disease (IBD) Market by Region
3.4 Global Esophageal Cancer Market by Region
3.5 Global Stomach Cancer Market by Region
3.6 Global Others Market by Region
Chapter 4. Global Nasogastric Tube Market by Patient Type
4.1 Global Adult Market by Region
4.2 Global Geriatric Market by Region
4.3 Global Pediatric Market by Region
Chapter 5. Global Nasogastric Tube Market by Type
5.1 Global Small-bore Feeding Tubes Market by Region
5.2 Global Large-bore Feeding Tubes Market by Region
Chapter 6. Global Nasogastric Tube Market by End-Use
6.1 Global Hospitals & Nursing Homes Market by Region
6.2 Global Home Care Market by Region
Chapter 7. Global Nasogastric Tube Market by Region
7.1 North America Nasogastric Tube Market
7.1.1 North America Nasogastric Tube Market by Indication
7.1.1.1 North America Dysphagia Market by Country
7.1.1.2 North America Chronic Kidney Disease Market by Country
7.1.1.3 North America Inflammatory Bowel Disease (IBD) Market by Country
7.1.1.4 North America Esophageal Cancer Market by Country
7.1.1.5 North America Stomach Cancer Market by Country
7.1.1.6 North America Others Market by Country
7.1.2 North America Nasogastric Tube Market by Patient Type
7.1.2.1 North America Adult Market by Country
7.1.2.2 North America Geriatric Market by Country
7.1.2.3 North America Pediatric Market by Country
7.1.3 North America Nasogastric Tube Market by Type
7.1.3.1 North America Small-bore Feeding Tubes Market by Country
7.1.3.2 North America Large-bore Feeding Tubes Market by Country
7.1.4 North America Nasogastric Tube Market by End-Use
7.1.4.1 North America Hospitals & Nursing Homes Market by Country
7.1.4.2 North America Home Care Market by Country
7.1.5 North America Nasogastric Tube Market by Country
7.1.5.1 US Nasogastric Tube Market
7.1.5.1.1 US Nasogastric Tube Market by Indication
7.1.5.1.2 US Nasogastric Tube Market by Patient Type
7.1.5.1.3 US Nasogastric Tube Market by Type
7.1.5.1.4 US Nasogastric Tube Market by End-Use
7.1.5.2 Canada Nasogastric Tube Market
7.1.5.2.1 Canada Nasogastric Tube Market by Indication
7.1.5.2.2 Canada Nasogastric Tube Market by Patient Type
7.1.5.2.3 Canada Nasogastric Tube Market by Type
7.1.5.2.4 Canada Nasogastric Tube Market by End-Use
7.1.5.3 Mexico Nasogastric Tube Market
7.1.5.3.1 Mexico Nasogastric Tube Market by Indication
7.1.5.3.2 Mexico Nasogastric Tube Market by Patient Type
7.1.5.3.3 Mexico Nasogastric Tube Market by Type
7.1.5.3.4 Mexico Nasogastric Tube Market by End-Use
7.1.5.4 Rest of North America Nasogastric Tube Market
7.1.5.4.1 Rest of North America Nasogastric Tube Market by Indication
7.1.5.4.2 Rest of North America Nasogastric Tube Market by Patient Type
7.1.5.4.3 Rest of North America Nasogastric Tube Market by Type
7.1.5.4.4 Rest of North America Nasogastric Tube Market by End-Use
7.2 Europe Nasogastric Tube Market
7.2.1 Europe Nasogastric Tube Market by Indication
7.2.1.1 Europe Dysphagia Market by Country
7.2.1.2 Europe Chronic Kidney Disease Market by Country
7.2.1.3 Europe Inflammatory Bowel Disease (IBD) Market by Country
7.2.1.4 Europe Esophageal Cancer Market by Country
7.2.1.5 Europe Stomach Cancer Market by Country
7.2.1.6 Europe Others Market by Country
7.2.2 Europe Nasogastric Tube Market by Patient Type
7.2.2.1 Europe Adult Market by Country
7.2.2.2 Europe Geriatric Market by Country
7.2.2.3 Europe Pediatric Market by Country
7.2.3 Europe Nasogastric Tube Market by Type
7.2.3.1 Europe Small-bore Feeding Tubes Market by Country
7.2.3.2 Europe Large-bore Feeding Tubes Market by Country
7.2.4 Europe Nasogastric Tube Market by End-Use
7.2.4.1 Europe Hospitals & Nursing Homes Market by Country
7.2.4.2 Europe Home Care Market by Country
7.2.5 Europe Nasogastric Tube Market by Country
7.2.5.1 Germany Nasogastric Tube Market
7.2.5.1.1 Germany Nasogastric Tube Market by Indication
7.2.5.1.2 Germany Nasogastric Tube Market by Patient Type
7.2.5.1.3 Germany Nasogastric Tube Market by Type
7.2.5.1.4 Germany Nasogastric Tube Market by End-Use
7.2.5.2 UK Nasogastric Tube Market
7.2.5.2.1 UK Nasogastric Tube Market by Indication
7.2.5.2.2 UK Nasogastric Tube Market by Patient Type
7.2.5.2.3 UK Nasogastric Tube Market by Type
7.2.5.2.4 UK Nasogastric Tube Market by End-Use
7.2.5.3 France Nasogastric Tube Market
7.2.5.3.1 France Nasogastric Tube Market by Indication
7.2.5.3.2 France Nasogastric Tube Market by Patient Type
7.2.5.3.3 France Nasogastric Tube Market by Type
7.2.5.3.4 France Nasogastric Tube Market by End-Use
7.2.5.4 Russia Nasogastric Tube Market
7.2.5.4.1 Russia Nasogastric Tube Market by Indication
7.2.5.4.2 Russia Nasogastric Tube Market by Patient Type
7.2.5.4.3 Russia Nasogastric Tube Market by Type
7.2.5.4.4 Russia Nasogastric Tube Market by End-Use
7.2.5.5 Spain Nasogastric Tube Market
7.2.5.5.1 Spain Nasogastric Tube Market by Indication
7.2.5.5.2 Spain Nasogastric Tube Market by Patient Type
7.2.5.5.3 Spain Nasogastric Tube Market by Type
7.2.5.5.4 Spain Nasogastric Tube Market by End-Use
7.2.5.6 Italy Nasogastric Tube Market
7.2.5.6.1 Italy Nasogastric Tube Market by Indication
7.2.5.6.2 Italy Nasogastric Tube Market by Patient Type
7.2.5.6.3 Italy Nasogastric Tube Market by Type
7.2.5.6.4 Italy Nasogastric Tube Market by End-Use
7.2.5.7 Rest of Europe Nasogastric Tube Market
7.2.5.7.1 Rest of Europe Nasogastric Tube Market by Indication
7.2.5.7.2 Rest of Europe Nasogastric Tube Market by Patient Type
7.2.5.7.3 Rest of Europe Nasogastric Tube Market by Type
7.2.5.7.4 Rest of Europe Nasogastric Tube Market by End-Use
7.3 Asia Pacific Nasogastric Tube Market
7.3.1 Asia Pacific Nasogastric Tube Market by Indication
7.3.1.1 Asia Pacific Dysphagia Market by Country
7.3.1.2 Asia Pacific Chronic Kidney Disease Market by Country
7.3.1.3 Asia Pacific Inflammatory Bowel Disease (IBD) Market by Country
7.3.1.4 Asia Pacific Esophageal Cancer Market by Country
7.3.1.5 Asia Pacific Stomach Cancer Market by Country
7.3.1.6 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Nasogastric Tube Market by Patient Type
7.3.2.1 Asia Pacific Adult Market by Country
7.3.2.2 Asia Pacific Geriatric Market by Country
7.3.2.3 Asia Pacific Pediatric Market by Country
7.3.3 Asia Pacific Nasogastric Tube Market by Type
7.3.3.1 Asia Pacific Small-bore Feeding Tubes Market by Country
7.3.3.2 Asia Pacific Large-bore Feeding Tubes Market by Country
7.3.4 Asia Pacific Nasogastric Tube Market by End-Use
7.3.4.1 Asia Pacific Hospitals & Nursing Homes Market by Country
7.3.4.2 Asia Pacific Home Care Market by Country
7.3.5 Asia Pacific Nasogastric Tube Market by Country
7.3.5.1 China Nasogastric Tube Market
7.3.5.1.1 China Nasogastric Tube Market by Indication
7.3.5.1.2 China Nasogastric Tube Market by Patient Type
7.3.5.1.3 China Nasogastric Tube Market by Type
7.3.5.1.4 China Nasogastric Tube Market by End-Use
7.3.5.2 Japan Nasogastric Tube Market
7.3.5.2.1 Japan Nasogastric Tube Market by Indication
7.3.5.2.2 Japan Nasogastric Tube Market by Patient Type
7.3.5.2.3 Japan Nasogastric Tube Market by Type
7.3.5.2.4 Japan Nasogastric Tube Market by End-Use
7.3.5.3 India Nasogastric Tube Market
7.3.5.3.1 India Nasogastric Tube Market by Indication
7.3.5.3.2 India Nasogastric Tube Market by Patient Type
7.3.5.3.3 India Nasogastric Tube Market by Type
7.3.5.3.4 India Nasogastric Tube Market by End-Use
7.3.5.4 South Korea Nasogastric Tube Market
7.3.5.4.1 South Korea Nasogastric Tube Market by Indication
7.3.5.4.2 South Korea Nasogastric Tube Market by Patient Type
7.3.5.4.3 South Korea Nasogastric Tube Market by Type
7.3.5.4.4 South Korea Nasogastric Tube Market by End-Use
7.3.5.5 Singapore Nasogastric Tube Market
7.3.5.5.1 Singapore Nasogastric Tube Market by Indication
7.3.5.5.2 Singapore Nasogastric Tube Market by Patient Type
7.3.5.5.3 Singapore Nasogastric Tube Market by Type
7.3.5.5.4 Singapore Nasogastric Tube Market by End-Use
7.3.5.6 Malaysia Nasogastric Tube Market
7.3.5.6.1 Malaysia Nasogastric Tube Market by Indication
7.3.5.6.2 Malaysia Nasogastric Tube Market by Patient Type
7.3.5.6.3 Malaysia Nasogastric Tube Market by Type
7.3.5.6.4 Malaysia Nasogastric Tube Market by End-Use
7.3.5.7 Rest of Asia Pacific Nasogastric Tube Market
7.3.5.7.1 Rest of Asia Pacific Nasogastric Tube Market by Indication
7.3.5.7.2 Rest of Asia Pacific Nasogastric Tube Market by Patient Type
7.3.5.7.3 Rest of Asia Pacific Nasogastric Tube Market by Type
7.3.5.7.4 Rest of Asia Pacific Nasogastric Tube Market by End-Use
7.4 LAMEA Nasogastric Tube Market
7.4.1 LAMEA Nasogastric Tube Market by Indication
7.4.1.1 LAMEA Dysphagia Market by Country
7.4.1.2 LAMEA Chronic Kidney Disease Market by Country
7.4.1.3 LAMEA Inflammatory Bowel Disease (IBD) Market by Country
7.4.1.4 LAMEA Esophageal Cancer Market by Country
7.4.1.5 LAMEA Stomach Cancer Market by Country
7.4.1.6 LAMEA Others Market by Country
7.4.2 LAMEA Nasogastric Tube Market by Patient Type
7.4.2.1 LAMEA Adult Market by Country
7.4.2.2 LAMEA Geriatric Market by Country
7.4.2.3 LAMEA Pediatric Market by Country
7.4.3 LAMEA Nasogastric Tube Market by Type
7.4.3.1 LAMEA Small-bore Feeding Tubes Market by Country
7.4.3.2 LAMEA Large-bore Feeding Tubes Market by Country
7.4.4 LAMEA Nasogastric Tube Market by End-Use
7.4.4.1 LAMEA Hospitals & Nursing Homes Market by Country
7.4.4.2 LAMEA Home Care Market by Country
7.4.5 LAMEA Nasogastric Tube Market by Country
7.4.5.1 Brazil Nasogastric Tube Market
7.4.5.1.1 Brazil Nasogastric Tube Market by Indication
7.4.5.1.2 Brazil Nasogastric Tube Market by Patient Type
7.4.5.1.3 Brazil Nasogastric Tube Market by Type
7.4.5.1.4 Brazil Nasogastric Tube Market by End-Use
7.4.5.2 Argentina Nasogastric Tube Market
7.4.5.2.1 Argentina Nasogastric Tube Market by Indication
7.4.5.2.2 Argentina Nasogastric Tube Market by Patient Type
7.4.5.2.3 Argentina Nasogastric Tube Market by Type
7.4.5.2.4 Argentina Nasogastric Tube Market by End-Use
7.4.5.3 UAE Nasogastric Tube Market
7.4.5.3.1 UAE Nasogastric Tube Market by Indication
7.4.5.3.2 UAE Nasogastric Tube Market by Patient Type
7.4.5.3.3 UAE Nasogastric Tube Market by Type
7.4.5.3.4 UAE Nasogastric Tube Market by End-Use
7.4.5.4 Saudi Arabia Nasogastric Tube Market
7.4.5.4.1 Saudi Arabia Nasogastric Tube Market by Indication
7.4.5.4.2 Saudi Arabia Nasogastric Tube Market by Patient Type
7.4.5.4.3 Saudi Arabia Nasogastric Tube Market by Type
7.4.5.4.4 Saudi Arabia Nasogastric Tube Market by End-Use
7.4.5.5 South Africa Nasogastric Tube Market
7.4.5.5.1 South Africa Nasogastric Tube Market by Indication
7.4.5.5.2 South Africa Nasogastric Tube Market by Patient Type
7.4.5.5.3 South Africa Nasogastric Tube Market by Type
7.4.5.5.4 South Africa Nasogastric Tube Market by End-Use
7.4.5.6 Nigeria Nasogastric Tube Market
7.4.5.6.1 Nigeria Nasogastric Tube Market by Indication
7.4.5.6.2 Nigeria Nasogastric Tube Market by Patient Type
7.4.5.6.3 Nigeria Nasogastric Tube Market by Type
7.4.5.6.4 Nigeria Nasogastric Tube Market by End-Use
7.4.5.7 Rest of LAMEA Nasogastric Tube Market
7.4.5.7.1 Rest of LAMEA Nasogastric Tube Market by Indication
7.4.5.7.2 Rest of LAMEA Nasogastric Tube Market by Patient Type
7.4.5.7.3 Rest of LAMEA Nasogastric Tube Market by Type
7.4.5.7.4 Rest of LAMEA Nasogastric Tube Market by End-Use
Chapter 8. Company Profiles
8.1 Becton, Dickinson and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Medtronic PLC
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.3 Cardinal Health, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.4 QMD
8.4.1 Company Overview
8.4.2 Recent Strategies and Developments
8.4.2.1 Product Launches and Product Expansions
8.5 Angiplast Pvt. Ltd.
8.5.1 Company Overview
8.6 Securmed Spa
8.6.1 Company Overview
8.7 Vygon SAS
8.7.1 Company Overview
8.8 Andersen Products, Inc. (Weiler Abrasives Group)
8.8.1 Company Overview
8.9 Guangdong Baihe Medical Technology Co., Ltd.
8.9.1 Company Overview
8.10. Poly Medicure Ltd.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses

Companies Mentioned

  • Becton, Dickinson and Company
  • Medtronic PLC
  • Cardinal Health, Inc.
  • QMD
  • Angiplast Pvt. Ltd.
  • Securmed Spa
  • Vygon SAS
  • Andersen Products, Inc. (Weiler Abrasives Group)
  • Guangdong Baihe Medical Technology Co., Ltd.
  • Poly Medicure Ltd.

Methodology

Loading
LOADING...